| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| RiverVest Venture Fund III, L.P. | 4.2% | $140,762 | 1,759,521 | John P. McKearn, Ph.D. | 07 Jan 2025 |
As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of SPRUCE BIOSCIENCES, INC. - Common Stock, par value $0.0001 per share (SPRB). This represents 0% of the company’s total 41,893,357 outstanding shares.
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q3 | 0 | $0 | -$146,574 | $0.07 | 0 |
| 2025 Q2 | 2,046,828 | $146,574 | -$2,433,360 | $0.07 | 3 |
| 2025 Q1 | 10,436,798 | $3,024,802 | -$321,461 | $0.29 | 30 |
| 2024 Q4 | 11,164,918 | $4,686,111 | +$183,106 | $0.42 | 30 |
| 2024 Q3 | 13,598,951 | $6,399,774 | -$1,537,557 | $0.47 | 29 |
| 2024 Q2 | 16,573,655 | $8,601,460 | -$1,330,613 | $0.52 | 36 |
| 2024 Q1 | 17,968,530 | $14,122,228 | -$48,624,275 | $0.79 | 49 |
| 2023 Q4 | 32,256,406 | $94,395,094 | -$2,945,462 | $2.93 | 40 |
| 2023 Q3 | 31,887,003 | $71,977,719 | -$177,344 | $2.26 | 41 |
| 2023 Q2 | 31,965,361 | $68,724,289 | -$3,880,411 | $2.15 | 39 |
| 2023 Q1 | 33,758,488 | $74,521,749 | +$39,533,296 | $2.21 | 44 |
| 2022 Q4 | 18,240,239 | $19,982,773 | -$50,960 | $1.10 | 30 |
| 2022 Q3 | 18,044,145 | $24,737,766 | +$2,300,031 | $1.37 | 30 |
| 2022 Q2 | 16,375,954 | $28,493,706 | -$1,235,202 | $1.74 | 30 |
| 2022 Q1 | 17,089,653 | $34,351,000 | -$1,832,781 | $2.01 | 41 |
| 2021 Q4 | 15,551,600 | $69,378,000 | -$13,260,253 | $4.46 | 48 |
| 2021 Q3 | 17,491,470 | $105,151,000 | -$12,936,894 | $6.01 | 42 |
| 2021 Q2 | 17,947,848 | $201,197,000 | +$10,306,769 | $11.21 | 40 |
| 2021 Q1 | 16,719,781 | $277,547,000 | -$943,154 | $16.60 | 39 |
| 2020 Q4 | 16,730,339 | $406,705,000 | +$406,704,983 | $24.31 | 44 |